Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.

Kuehl PJ, Grimes MJ, Dubose D, Burke M, Revelli DA, Gigliotti AP, Belinsky SA, Tessema M

DOI: 10.1080/10717544.2018.1469688
Published: 2018 Nov
Container: Drug delivery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/10717544.2018.1469688,
  title = {Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.},
  author = {Kuehl PJ and Grimes MJ and Dubose D and Burke M and Revelli DA and Gigliotti AP and Belinsky SA and Tessema M},
  year = {2018},
  journal = {Drug delivery},
  doi = {10.1080/10717544.2018.1469688},
  url = {https://doi.org/10.1080/10717544.2018.1469688}
}

RIS

TY  - JOUR
TI  - Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.
AU  - Kuehl PJ
AU  - Grimes MJ
AU  - Dubose D
AU  - Burke M
AU  - Revelli DA
AU  - Gigliotti AP
AU  - Belinsky SA
AU  - Tessema M
PY  - 2018
JO  - Drug delivery
DO  - 10.1080/10717544.2018.1469688
UR  - https://doi.org/10.1080/10717544.2018.1469688
ER  -

APA

PJ, K., MJ, G., D, D., M, B., DA, R., AP, G., SA, B., & M, T. (2018). Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.. Drug delivery. https://doi.org/10.1080/10717544.2018.1469688

Source records

pubmed · retrieved 2026-09-27T12:25:43.449Z